Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Maravai LifeSciences Holdings Inc MRVI

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene... see more

Recent & Breaking News (NDAQ:MRVI)

Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders

GlobeNewswire September 7, 2021

Maravai LifeSciences Announces September 2021 Investor Conference Schedule

GlobeNewswire September 7, 2021

Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance

GlobeNewswire August 10, 2021

TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok

GlobeNewswire August 2, 2021

Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology

GlobeNewswire July 21, 2021

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021

GlobeNewswire July 20, 2021

Maravai LifeSciences Announces June 2021 Investor Conference Schedule

GlobeNewswire May 26, 2021

Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance

GlobeNewswire May 10, 2021

Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021

GlobeNewswire May 5, 2021

Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors

GlobeNewswire April 20, 2021

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021

GlobeNewswire April 13, 2021

Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire April 12, 2021

Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders

GlobeNewswire April 7, 2021

Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders

GlobeNewswire April 5, 2021

Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range

GlobeNewswire April 5, 2021

Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services

GlobeNewswire March 15, 2021

Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance

GlobeNewswire March 2, 2021

Maravai LifeSciences Announces March 2021 Investor Conference Schedule

GlobeNewswire March 1, 2021

Maravai LifeSciences Expands Its Intellectual Property Portfolio

GlobeNewswire February 10, 2021

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021

GlobeNewswire January 28, 2021